Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Super League Enterprise
SLE
$5.44M
| $145K | ﹤0.01% |
15
-14
| -48% | -$182K |
|
|
MAAS
3752
Maase Inc
MAAS
$7.26B
| $145K | ﹤0.01% |
297
+3
| +1% | +$1.2K |
|
|
NBRV
3753
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $145K | ﹤0.01% |
31,838
+16,086
| +102% | +$105K |
|
3754
Evolus
EOLS
$536M
| $144K | ﹤0.01% |
+12,400
| New | +$146K |
|
|
AGRX
3755
DELISTED
Agile Therapeutics
AGRX
| $143K | ﹤0.01% |
2,449
+2,138
| +687% | +$310K |
|
3756
Fusion Fuel Green
HTOO
$17.9M
| $141K | ﹤0.01% |
+617
| New | +$172K |
|
|
ERUS
3757
DELISTED
iShares MSCI Russia ETF
ERUS
| $141K | ﹤0.01% |
175,200
| – | – |
|
3758
Asure Software
ASUR
$241M
| $139K | ﹤0.01% |
24,300
-76,600
| -76% | -$456K |
|
3759
Immuneering
IMRX
$328M
| $138K | ﹤0.01% |
25,537
-32,063
| -56% | -$171K |
|
|
HHR
3760
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $138K | ﹤0.01% |
92,100
| – | – |
|
3761
Key Tronic
KTCC
$41.9M
| $136K | ﹤0.01% |
30,734
-18,166
| -37% | -$93.9K |
|
|
ORGS
3762
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $136K | ﹤0.01% |
5,630
-140
| -2% | -$3.9K |
|
|
BSQR
3763
DELISTED
BSQUARE Corporation
BSQR
| $136K | ﹤0.01% |
107,747
-57,382
| -35% | -$81.3K |
|
|
TTNP
3764
DELISTED
Titan Pharmaceuticals
TTNP
| $135K | ﹤0.01% |
12,036
+10,210
| +559% | +$127K |
|
3765
Banco Macro
BMA
$5.1B
| $134K | ﹤0.01% |
+12,000
| New | +$178K |
|
3766
electroCore
ECOR
$84.7M
| $134K | ﹤0.01% |
17,541
+8,866
| +102% | +$64.1K |
|
|
HEPA
3767
DELISTED
Hepion Pharmaceuticals
HEPA
| $134K | ﹤0.01% |
235
+108
| +85% | +$89.9K |
|
|
WKME
3768
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $133K | ﹤0.01% |
+13,100
| New | +$163K |
|
|
SIEN
3769
DELISTED
Sientra, Inc.
SIEN
| $133K | ﹤0.01% |
15,899
-4,978
| -24% | -$67.8K |
|
3770
Dolphin Entertainment
DLPN
$14.8M
| $132K | ﹤0.01% |
20,900
+1,830
| +10% | +$13.8K |
|
3771
ENDRA Life Sciences
NDRA
$5.68M
| $132K | ﹤0.01% |
16
+6
| +60% | +$53.7K |
|
3772
Pluri
PLUR
$17.5M
| $132K | ﹤0.01% |
13,413
+3,950
| +42% | +$48.6K |
|
|
ASXC
3773
DELISTED
Asensus Surgical, Inc.
ASXC
| $132K | ﹤0.01% |
331,064
-1,057,138
| -76% | -$472K |
|
|
LIAN
3774
DELISTED
LianBio American Depositary Shares
LIAN
| $132K | ﹤0.01% |
60,900
+24,376
| +67% | +$82.8K |
|
3775
GEE Group
JOB
$22.2M
| $130K | ﹤0.01% |
249,970
+215,770
| +631% | +$124K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.